Allergan Hit With Off-Label Marketing FCA Suit
Caryatid LLC accused Allergan Inc. of False Claims Act violations for marketing eye care drugs for off-label uses in kits it sold to ophthalmologists, some of whom likely filed for federal...To view the full article, register now.
Already a subscriber? Click here to view full article